JANUARY 30 • 2020 | 45 O ne of the scariest things about being admitted to the hospital is the possibility of catch- ing some dangerous, drug-resistant super- bug. The chances of that happening could become slimmer with a new discovery from Israeli researchers, who found that aggressive bacteria can be controlled if treated within a specific timeframe. Like all living organisms, bacteria develop defenses against hostile elements in their environment — in their case, antibiotics. They can do so by acting “tolerant” and lying dormant during antibiotic treat- ment which misses them because it only knows how to spot and kill growing targets. After evading this round of treatment, the bacteria become resilient. It’ s this “tolerant” stage that Professor Nathalie Balaban from the Hebrew University of Jerusalem and Dr. Maskit Bar-Meir from Shaare Zedek Medical Center have tackled, with their findings recently published in Science magazine. Bearing in mind that the tolerance stage lasts only a few days and can’ t be detected in standard medical labs, the two developed a lab test that gauges antibiotic tolerance. This means that doctors can now administer the correct medication within this narrow timeframe before resistance sets in. In a previous study, Balaban developed a mathematical model that described, mea- sured and predicted when bac- teria would develop tolerance to a particular antibiotic. Now, Balaban repeated the study together with Bar-Meir, this time analyzing daily bacterial samples from hospitalized patients with life-threatening, persistent MRSA (methicil- lin-resistant Staphylococcus aureus) infections. Like in the lab, the bacteria developed tolerance followed by resistance, leading to the failure of antibiotic treatment. If medical centers adopt this lab test, doctors could quickly and easily detect whether a patient’ s bacteria are tolerant of a planned antibiotic treat- ment before it’ s administered. Based on the patient’ s bacteria profile, doctors could also handpick antibiotics with a greater chance of success. “Using the right combi- nation of available antibiotic drugs at the outset could dra- matically increase a patient’ s survival rate before their infec- tion becomes tolerant to all the antibiotics in our arsenal,” Balaban explained. From UnitedWithIsrael.org Excellent Pay Flexible Hours Paid Training Apply Online Today! 2020 Census Jobs Available! Form D-467 September 2018 2020census.gov/jobs 1-855-JOB-2020 (1-855-562-2020) Federal Relay Service: (800) 877-8339 TTY / ASCII www.gsa.gov/fedrelay business with and within the federal government. The U.S. Census Bureau is an Equal Opportunity Employer. Israeli Doctors Take on Life-threatening Superbugs NAAMA BARAK ISRAEL21C.ORG Professor Nathalie Balaban HEBREW UNIVERSITY